Quality generics from Zentiva

Featured News

Sanofi and Advent finalize negotiations for the acquisition of Zentiva

June 28, 2018

Read more

Featured News

Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business

April 17, 2018

Read more

Zentiva's key therapeutic areas:

  • Cardiovascular
  • Central nervous system
  • Gastrointestinal and metabolic disorders
  • Anti-inflammatory and pain
  • Blood disorders
  • Anti-infectives
  • Urology
  • Respiratory

Other:

  • Endocrinology
  • Oncology
  • Dermatology
  • Hospital Solutions

Meet our people

Meet our people

Zentiva has made significant progress in developing its business in order to provide the optimal platform for its ambitious growth plans in Europe.


Patrick Aghanian, Head of Zentiva

Responsibility

Patients
Patients
Employees
Employees
Environment
Environment

Zentiva is the third* largest and fast growing generics company in Europe.

Products

Learn about generics and pharmaceuticals

Careers

Work with us

Media

Stay up to date with the latest news
* IMS data (volume) 09/2016

Copyright Zentiva Group, a.s. © 2017

Last updated on: 02.07.2018